Medtronic PLC
2M6.XETRA
Exchange: | XETRA |
Currency | Euro |
ISIN: | IE00BTN1Y115 |
LEI: | 549300GX3ZBSQWUXY261 |
Fiscal Year End: | April |
Sector: | Healthcare |
Industry: | Medical Devices |
Gic Sector: | Health Care |
Gic Group: | Health Care Equipment & Services |
Gic Industry: | Health Care Equipment & Supplies |
Gic Sub Industry: | Health Care Equipment |
Description: | Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and In Pen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland. |
Address: | Building Two, Galway, Ireland |
Website: | https://www.medtronic.com |
Full Time Employees: | 95000 |
Updated On: | 2024-11-04 |
Highlights
Market Capitalization: | 105724715008 |
Market Capitalization Mln: | 105724.71 |
EBITDA: | 9013000192 |
PE Ratio: | 30.19 |
PEG Ratio: | 1.68 |
Book Value: | 37.38 |
Dividend Share: | 2.77 |
Dividend Yield: | 0.03 |
Earnings Share: | 2.73 |
Most Recent Quarter: | 2024-07-31 |
Profit Margin: | 0.12 |
Operating Margin TTM: | 0.17 |
Return On Assets TTM: | 0.04 |
Return On Equity TTM: | 0.07 |
Revenue TTM: | 32576999424 |
Revenue Per Share TTM: | 24.70 |
Quarterly Revenue Growth YOY: | 0.02 |
Gross Profit TTM: | 21715000000 |
Diluted Eps TTM: | 2.73 |
Quarterly Earnings Growth YOY: | 0.35 |
Valuation
Trailing PE: | 30.19 |
Forward PE: | 16.69 |
Price Sales TTM: | 3.24 |
Price Book MRQ: | 2.43 |
Enterprise Value: | 124536771791 |
Enterprise Value Revenue: | 4.16 |
Enterprise Value Ebitda: | 16.36 |
Shares
Shares Outstanding: | 1282599936 |
Shares Float: | 1280387209 |
Percent Insiders: | 0.25 |
Percent Institutions: | 85.73 |
Technicals
Beta: | 0.85 |
52 Week High: | 86 |
52 Week Low: | 62.67 |
50 Day MA: | 81.41 |
200 Day MA: | 77.57 |
Splits & Dividends
Forward Annual Dividend Rate: | 2.56 |
Forward Annual Dividend Yield: | 0.03 |
Payout Ratio: | 1.01 |
Ex Dividend Date: | 2024-09-27 |
Earnings
Report Date: | 2025-08-18 |
Date: | 2025-07-31 |
Before After Market: | After Market |
Currency: | USD |
Report Date: | 2025-05-22 |
Date: | 2025-04-30 |
Before After Market: | After Market |
Currency: | USD |
Report Date: | 2025-02-18 |
Date: | 2025-01-31 |
Before After Market: | After Market |
Currency: | USD |
Report Date: | 2024-11-19 |
Date: | 2024-10-31 |
Before After Market: | After Market |
Currency: | USD |
Report Date: | 2024-08-20 |
Date: | 2024-07-31 |
Before After Market: | After Market |
Currency: | USD |
Eps Actual: | 0.74 |
Report Date: | 2024-05-23 |
Date: | 2024-04-30 |
Before After Market: | After Market |
Currency: | USD |
Eps Actual: | 0.45 |
Report Date: | 2024-04-07 |
Date: | 2024-01-31 |
Before After Market: | After Market |
Currency: | USD |
Eps Actual: | 0.91 |
Report Date: | 2024-01-08 |
Date: | 2023-10-31 |
Before After Market: | After Market |
Currency: | USD |
Eps Actual: | 0.63 |
Report Date: | 2023-07-31 |
Date: | 2023-07-31 |
Currency: | USD |
Eps Actual: | 0.54 |
Report Date: | 2023-04-30 |
Date: | 2023-04-30 |
Currency: | USD |
Eps Actual: | 0.82 |
Report Date: | 2023-01-31 |
Date: | 2023-01-31 |
Currency: | USD |
Eps Actual: | 0.87 |
Report Date: | 2022-10-31 |
Date: | 2022-10-31 |
Currency: | USD |
Eps Actual: | 0.32 |
Report Date: | 2022-07-31 |
Date: | 2022-07-31 |
Currency: | USD |
Eps Actual: | 0.66 |
Report Date: | 2022-04-30 |
Date: | 2022-04-30 |
Currency: | USD |
Eps Actual: | 0.99 |
Report Date: | 2022-01-31 |
Date: | 2022-01-31 |
Currency: | USD |
Eps Actual: | 0.96 |
Report Date: | 2021-10-31 |
Date: | 2021-10-31 |
Currency: | USD |
Eps Actual: | 0.82 |
Report Date: | 2021-07-31 |
Date: | 2021-07-31 |
Currency: | USD |
Eps Actual: | 0.46 |
Report Date: | 2021-04-30 |
Date: | 2021-04-30 |
Currency: | USD |
Eps Actual: | 0.83 |
Report Date: | 2021-01-31 |
Date: | 2021-01-31 |
Currency: | USD |
Eps Actual: | 0.77 |
Report Date: | 2020-10-31 |
Date: | 2020-10-31 |
Currency: | USD |
Eps Actual: | 0.30 |
Report Date: | 2020-07-31 |
Date: | 2020-07-31 |
Currency: | USD |
Eps Actual: | 0.32 |
Report Date: | 2020-04-30 |
Date: | 2020-04-30 |
Currency: | USD |
Eps Actual: | 0.43 |
Report Date: | 2020-01-31 |
Date: | 2020-01-31 |
Currency: | USD |
Eps Actual: | 1.27 |
Report Date: | 2019-10-31 |
Date: | 2019-10-31 |
Currency: | USD |
Eps Actual: | 0.91 |
Report Date: | 2019-07-31 |
Date: | 2019-07-31 |
Currency: | USD |
Eps Actual: | 0.56 |
Report Date: | 2019-04-30 |
Date: | 2019-04-30 |
Currency: | USD |
Eps Actual: | 0.76 |
Report Date: | 2019-01-31 |
Date: | 2019-01-31 |
Currency: | USD |
Eps Actual: | 0.82 |
Report Date: | 2018-10-31 |
Date: | 2018-10-31 |
Currency: | USD |
Eps Actual: | 0.70 |
Report Date: | 2018-07-31 |
Date: | 2018-07-31 |
Currency: | USD |
Eps Actual: | 0.67 |
Report Date: | 2018-04-30 |
Date: | 2018-04-30 |
Currency: | USD |
Eps Actual: | 0.86 |
Report Date: | 2018-01-31 |
Date: | 2018-01-31 |
Currency: | USD |
Eps Actual: | -0.86 |
Report Date: | 2017-10-31 |
Date: | 2017-10-31 |
Currency: | USD |
Eps Actual: | 1.24 |
Report Date: | 2017-07-31 |
Date: | 2017-07-31 |
Currency: | USD |
Eps Actual: | 0.65 |
Report Date: | 2017-04-30 |
Date: | 2017-04-30 |
Currency: | USD |
Eps Actual: | 0.78 |
Report Date: | 2017-01-31 |
Date: | 2017-01-31 |
Currency: | USD |
Eps Actual: | 0.55 |
Report Date: | 2016-10-31 |
Date: | 2016-10-31 |
Currency: | USD |
Eps Actual: | 0.71 |
Report Date: | 2016-07-31 |
Date: | 2016-07-31 |
Currency: | USD |
Eps Actual: | 0.58 |
Report Date: | 2016-04-30 |
Date: | 2016-04-30 |
Currency: | USD |
Eps Actual: | 0.69 |
Report Date: | 2016-01-31 |
Date: | 2016-01-31 |
Currency: | USD |
Eps Actual: | 0.71 |
Report Date: | 2015-10-31 |
Date: | 2015-10-31 |
Currency: | USD |
Eps Actual: | 0.32 |
Date: | 2024-10-31 |
Eps Actual: | 0.74 |
Date: | 2024-04-30 |
Eps Actual: | 2.55 |
Date: | 2023-04-30 |
Eps Actual: | 2.68 |
Date: | 2022-04-30 |
Eps Actual: | 3.26 |
Date: | 2021-04-30 |
Eps Actual: | 2.24 |
Date: | 2020-04-30 |
Eps Actual: | 3.19 |
Date: | 2019-04-30 |
Eps Actual: | 2.97 |
Date: | 2018-04-30 |
Eps Actual: | 1.91 |
Date: | 2017-04-30 |
Eps Actual: | 2.65 |
Date: | 2016-04-30 |
Eps Actual: | 1.73 |